Skip to main content
OpenTrials
Completed

NCT Number: NCT00931320

Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients

An observational, non-interventional, multi-centre study to provide further information on the ratio of LDL-C to HDL-C improvement after statin treatment in Korean patients group.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects who are taking lipid-lowering medication after diagnosed as dyslipidaemia
  • Subjects who have at least made 1 visit to the outpatient clinic within previous 6 months
  • Subjects who have records of both LDL-C and HDL-C before & after statin treatment (at least four weeks after statin taking)

Exclusion criteria

  • Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

Treatment and study plan

Primary outcomes

  1. Evaluate current LDL/HDL ratio in Korean patients (between baseline & after treatment)

    Time frame: After Treatment : at least 4 weeks before statin taking /Baseline : no limitation.

Secondary outcomes

  1. Evaluate difference of LDL/HDL ratio among different statins & dosages (between baseline & after treatment)

    Time frame: After Treatment : at least 4 weeks before statin taking / Baseline : no limitation.

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: RACHEL

Important dates

Study start
2009
Study completion
2009
First posted
Jul 2, 2009
Registry last updated
Oct 27, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.